The Effect of Pluchea indica (L.) Less. Tea on Blood Glucose and Lipid Profile in People with Prediabetes: A Randomized Clinical Trial.

IF 2.3 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE
Kittipot Sirichaiwetchakoon, Seekaow Churproong, Sajeera Kupittayanant, Griangsak Eumkeb
{"title":"The Effect of <i>Pluchea indica</i> (L.) Less. Tea on Blood Glucose and Lipid Profile in People with Prediabetes: A Randomized Clinical Trial.","authors":"Kittipot Sirichaiwetchakoon,&nbsp;Seekaow Churproong,&nbsp;Sajeera Kupittayanant,&nbsp;Griangsak Eumkeb","doi":"10.1089/acm.2020.0246","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Objective:</i></b> Diabetes mellitus and dyslipidemia are currently increasing dramatically, and conventional medicine in the treatment of them has limited efficacies and serious adverse effects. <i>Pluchea indica</i> (L.) Less. tea (PIT) is widely consumed as a health-promoting drink in Southeast Asia. This study aimed to investigate whether <i>P. indica</i> tea has antidyslipidemic and antihyperglycemic effects and toxicity in humans. <b><i>Design:</i></b> A randomized clinical trial. <b><i>Setting/Location:</i></b> Nakhonratchasima, Thailand. <b><i>Participants:</i></b> Forty-five participants with prediabetes. <b><i>Interventions:</i></b> Participants were randomized to receive placebo tea, 1.5 g of PIT, and 1.5 g <i>Camellia sinensis</i> tea (green tea, CST) once daily for 12 weeks. <b><i>Outcome Measurements:</i></b> The oral glucose tolerance test (OGTT), total cholesterol, triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), blood urea nitrogen (BUN), creatinine, alanine transaminase (ALT), alkaline phosphatase (ALP), and complete blood count (CBC) before and after treatment were investigated. <b><i>Results:</i></b> The results showed that PIT significantly ameliorated hyperglycemia and significantly lower serum TG (109.22 ± 5.21 mg/dL) and LDL-C (122.20 ± 3.67 mg/dL) than placebo (145.56 ± 8.18 and 142.07 ± 8.58 mg/dL, respectively) (<i>p</i> < 0.05). Moreover, PIT exhibited serum TG (109.22 ± 5.21 mg/dL) significantly lower than CST (124.38 ± 4.70 mg/dL) (<i>p</i> < 0.05). In addition, the serum HDL-C of PIT (57.56 ± 3.05 mg/dL) was significantly higher than the placebo (46.44 ± 2.47 mg/dL) (<i>p</i> < 0.05). Furthermore, the toxicity testing showed that no significant difference in BUN, creatinine, ALT, ALP, and CBC of PIT-treated group compared with the placebo (<i>p</i> > 0.05). <b><i>Conclusions:</i></b> These results suggest that PIT may ameliorate hyperglycemia and dyslipidemia in prediabetes people. It may not be toxic to the kidney, liver, and blood. So, PIT has the potential to develop to be a health-promoting tea or herbal medicine for hyperglycemia and dyslipidemia prevention.</p>","PeriodicalId":14944,"journal":{"name":"Journal of alternative and complementary medicine","volume":"27 8","pages":"669-677"},"PeriodicalIF":2.3000,"publicationDate":"2021-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of alternative and complementary medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/acm.2020.0246","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/6/1 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 7

Abstract

Objective: Diabetes mellitus and dyslipidemia are currently increasing dramatically, and conventional medicine in the treatment of them has limited efficacies and serious adverse effects. Pluchea indica (L.) Less. tea (PIT) is widely consumed as a health-promoting drink in Southeast Asia. This study aimed to investigate whether P. indica tea has antidyslipidemic and antihyperglycemic effects and toxicity in humans. Design: A randomized clinical trial. Setting/Location: Nakhonratchasima, Thailand. Participants: Forty-five participants with prediabetes. Interventions: Participants were randomized to receive placebo tea, 1.5 g of PIT, and 1.5 g Camellia sinensis tea (green tea, CST) once daily for 12 weeks. Outcome Measurements: The oral glucose tolerance test (OGTT), total cholesterol, triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), blood urea nitrogen (BUN), creatinine, alanine transaminase (ALT), alkaline phosphatase (ALP), and complete blood count (CBC) before and after treatment were investigated. Results: The results showed that PIT significantly ameliorated hyperglycemia and significantly lower serum TG (109.22 ± 5.21 mg/dL) and LDL-C (122.20 ± 3.67 mg/dL) than placebo (145.56 ± 8.18 and 142.07 ± 8.58 mg/dL, respectively) (p < 0.05). Moreover, PIT exhibited serum TG (109.22 ± 5.21 mg/dL) significantly lower than CST (124.38 ± 4.70 mg/dL) (p < 0.05). In addition, the serum HDL-C of PIT (57.56 ± 3.05 mg/dL) was significantly higher than the placebo (46.44 ± 2.47 mg/dL) (p < 0.05). Furthermore, the toxicity testing showed that no significant difference in BUN, creatinine, ALT, ALP, and CBC of PIT-treated group compared with the placebo (p > 0.05). Conclusions: These results suggest that PIT may ameliorate hyperglycemia and dyslipidemia in prediabetes people. It may not be toxic to the kidney, liver, and blood. So, PIT has the potential to develop to be a health-promoting tea or herbal medicine for hyperglycemia and dyslipidemia prevention.

梅花(L.)的药效更少。茶对糖尿病前期患者血糖和血脂的影响:一项随机临床试验。
目的:目前糖尿病和血脂异常患者急剧增加,常规药物治疗效果有限,不良反应严重。梅花(L.)更少。茶(PIT)作为一种促进健康的饮料在东南亚被广泛消费。本研究旨在探讨印度茶是否具有降血脂和降高血糖的作用及其对人体的毒性。设计:随机临床试验。场景/地点:泰国Nakhonratchasima。参与者:45名糖尿病前期患者。干预措施:参与者随机接受安慰剂茶,1.5 g PIT和1.5 g茶树茶(绿茶,CST),每天一次,持续12周。观察结果:观察治疗前后口服糖耐量试验(OGTT)、总胆固醇、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、血尿素氮(BUN)、肌酐、丙氨酸转氨酶(ALT)、碱性磷酸酶(ALP)、全血细胞计数(CBC)。结果:PIT明显改善高血糖,血清TG(109.22±5.21 mg/dL)和LDL-C(122.20±3.67 mg/dL)明显低于安慰剂(分别为145.56±8.18和142.07±8.58 mg/dL) (p p p p > 0.05)。结论:这些结果表明PIT可以改善糖尿病前期患者的高血糖和血脂异常。它可能对肾、肝和血液没有毒性。因此,PIT有潜力发展成为一种促进健康的茶或草药,用于预防高血糖和血脂异常。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of alternative and complementary medicine
Journal of alternative and complementary medicine 医学-全科医学与补充医学
CiteScore
4.00
自引率
0.00%
发文量
0
审稿时长
3 months
期刊介绍: The Journal of Alternative and Complementary Medicine: Paradigm, Practice, and Policy Advancing Integrative Health is the leading peer-reviewed journal providing scientific research for the evaluation and integration of complementary and alternative medicine into mainstream medical practice. The Journal delivers original research that directly impacts patient care therapies, protocols, and strategies, ultimately improving the quality of healing. The Journal of Alternative and Complementary Medicine coverage includes: -Botanical Medicine -Acupuncture and Traditional Chinese Medicine -Other Traditional Medicine Practices -Mind-Body Medicine -Nutrition and Dietary Supplements -Integrative Health / Medicine -Yoga -Ayurveda -Naturopathy -Creative Arts Therapies -Integrative Whole Systems / Whole Practices -Homeopathy -Tai Chi -Qi Gong -Massage Therapy -Subtle Energies and Energy Medicine -Integrative Cost Studies / Comparative Effectiveness -Neurostimulation -Integrative Biophysics
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信